Literature DB >> 20300993

Simultaneous detection of bluetongue virus RNA, internal control GAPDH mRNA, and external control synthetic RNA by multiplex real-time PCR.

Frank Vandenbussche1, Elise Vandemeulebroucke, Kris De Clercq.   

Abstract

Bluetongue is an insect-borne disease of domestic and wild ruminants that requires strict monitoring by sensitive, reproducible and robust methods. Real-time reverse transcription polymerase chain reaction (RT-qPCR) analysis has become the method of choice for routine viral diagnosis. As false-negative test results can have serious implications; an internal/external control system should be incorporated in each analysis to detect RT-qPCR failure due to poor sample quality, improper nucleic acid extraction and/or PCR inhibition. To increase the diagnostic capacity and reduce costs, it is recommended to use a multiplex strategy which enables the amplification of multiple targets in a single reaction. This chapter describes the application of a triplex RT-qPCR for the simultaneous detection of bluetongue viral RNA, an internal control and an external control. The primer and probe sequences of the BTV RT-qPCR were taken from Toussaint et al. (J Virol Methods 140:115-123, 2007), whereas the internal and external RT-qPCRs were specifically designed to detect endogenous glyceraldehyde-3-phosphate dehydrogenase mRNA and a synthetic RNA, respectively. To maximize the sensitivity of the assay, the primer concentrations of the internal/external control reactions were limited and the amount of Taq DNA polymerase was increased. A comparison of the singleplex versus triplex RT-qPCR indicated that the triplex RT-qPCR exhibits a higher analytical sensitivity. Due to the incorporation of the internal/external control system, the triplex RT-qPCR allows an even more reliable and rapid diagnosis of bluetongue than the previously described singleplex RT-qPCR (J Virol Methods 140:115-123, 2007).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20300993     DOI: 10.1007/978-1-60761-629-0_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  qRT-PCR: a method and its difficulties.

Authors:  Franziska Bollmann; Ingrid Casper; Jenny Henke; Andrea Pautz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-08-04       Impact factor: 3.000

2.  Rapid generation of replication-deficient monovalent and multivalent vaccines for bluetongue virus: protection against virulent virus challenge in cattle and sheep.

Authors:  Cristina C P Celma; Mark Boyce; Piet A van Rijn; Michael Eschbaumer; Kerstin Wernike; Bernd Hoffmann; Martin Beer; Andy Haegeman; Kris De Clercq; Polly Roy
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

3.  Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines.

Authors:  Cristina C Celma; Meredith Stewart; Kerstin Wernike; Michael Eschbaumer; Lorenzo Gonzalez-Molleda; Emmanuel Breard; Claudia Schulz; Bernd Hoffmann; Andy Haegeman; Kris De Clercq; Stephan Zientara; Piet A van Rijn; Martin Beer; Polly Roy
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

4.  Expecting the unexpected: nucleic acid-based diagnosis and discovery of emerging viruses.

Authors:  Ross Thomas Barnard; Roy A Hall; Ernest A Gould
Journal:  Expert Rev Mol Diagn       Date:  2011-05       Impact factor: 5.225

5.  Orbivirus Screening from Imported Captive Oryx in the United Arab Emirates Stresses the Importance of Pre-Import and Transit Measures.

Authors:  Ludovic Martinelle; Andy Haegeman; Louis Lignereux; Anne-Lise Chaber; Fabiana Dal Pozzo; Ilse De Leeuw; Kris De Clercq; Claude Saegerman
Journal:  Pathogens       Date:  2022-06-17

6.  Failure to Remove Bluetongue Serotype 8 Virus (BTV-8) From in vitro Produced and in vivo Derived Bovine Embryos and Subsequent Transmission of BTV-8 to Recipient Cows After Embryo Transfer.

Authors:  Andy Haegeman; Leen Vandaele; Ilse De Leeuw; André P Oliveira; Hans Nauwynck; Ann Van Soom; Kris De Clercq
Journal:  Front Vet Sci       Date:  2019-12-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.